Perrigo

25.00
-0.15 (-0.60%)
At close: Jan 28, 2025, 1:54 PM

Company Description

Perrigo Company plc provides over-the-counter (OTC) health and wellness solutions that enhance individual well-being by empowering consumers to prevent or treat conditions that can be self-managed.

The company operates through two segments, Consumer Self-Care Americas and Consumer Self-Care International.

The Consumer Self-Care Americas segment focuses primarily on the development, manufacture, marketing, and sale of store brand, self-care products in categories, including upper respiratory, pain and sleep-aids, digestive health, nutrition, vitamins, minerals and supplements, healthy lifestyle, skincare and personal hygiene, and oral self-care in the United States, Mexico, Canada, and South America.

The segment offers its products under the Prevacid 24HR, Good Sense, Zephrex D, ScarAway, Plackers, Rembrandt, Steripod, Firefly, REACH, Dr. Fresh, and Burt's Bees brand names.

The Consumer Self-Care International segment develops, manufactures, markets, and distributes consumer self-care brands through a network of pharmacies, wholesalers, drug and grocery store retailers, and para-pharmacies in approximately 23 countries, primarily in Europe.

The company also offers contract manufacturing services.

Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.

Perrigo
Perrigo logo
Country IE
IPO Date Dec 17, 1991
Industry Drug Manufacturers - Specialty & Generic
Sector Healthcare
Employees 9,140
CEO Patrick Lockwood-Taylor

Contact Details

Address:
The Sharp Building
Dublin,
IE
Website https://www.perrigo.com

Stock Details

Ticker Symbol PRGO
Exchange NYSE
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001585364
CUSIP Number G97822103
ISIN Number IE00BGH1M568
Employer ID 00-0000000
SIC Code 2834

Key Executives

Name Position
Patrick Lockwood-Taylor President, Chief Executive Officer & Director
Eduardo Guarita Bezerra Executive Vice President & Chief Financial Officer
Abbie Lennox EVice President & Chief Scientific Officer
Bradley Joseph Vice President of Global Investor Relations & Corporate Communications
Catherine C. B. Schmelter Executive Vice President and President of Consumer Self-Care Americas & Global Portfolio Optimization
Charles Atkinson Executive Vice President, General Counsel & Secretary
Mary Reilly-Brest Director of Global Organizational and Human Resource Development
Robert Willis Chief Human Resources Officer & Executive Vice President
Ronald C. Janish Chief Transformation Officer and Executive Vice President of Global Operations & Supply Chain
Shannon Hukill Senior Director of Technical Operations

Latest SEC Filings

Date Type Title
Jan 16, 2025 8-K Current Report
Dec 20, 2024 8-K Current Report
Dec 16, 2024 25-NSE Filing
Dec 10, 2024 4 Filing
Nov 06, 2024 10-Q Quarterly Report
Nov 06, 2024 8-K/A [Amend] Current Report
Nov 06, 2024 8-K Current Report
Oct 31, 2024 SC 13G Statement of acquisition of beneficial ownership b...
Oct 17, 2024 4 Filing
Oct 10, 2024 CERT Filing